P01 66726/PHS HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1995	2
1996	3
1997	2
1999	1
2000	1
2001	2
2002	3
2003	1
2004	1
2024	0

1

Albelda SM, Wiewrodt R, Sterman DH. Albelda SM, et al. Clin Chest Med. 2002 Mar;23(1):265-77. doi: 10.1016/s0272-5231(03)00072-8. Clin Chest Med. 2002. PMID: 11901916 Review.

2

Gene therapy approaches for inherited and acquired lung diseases.

Curiel DT, Pilewski JM, Albelda SM. Curiel DT, et al. Am J Respir Cell Mol Biol. 1996 Jan;14(1):1-18. doi: 10.1165/ajrcmb.14.1.8534480. Am J Respir Cell Mol Biol. 1996. PMID: 8534480 Review.

3

Gene therapy for lung disease: hype or hope?

Albelda SM, Wiewrodt R, Zuckerman JB. Albelda SM, et al. Ann Intern Med. 2000 Apr 18;132(8):649-60. doi: 10.7326/0003-4819-132-8-200004180-00008. Ann Intern Med. 2000. PMID: 10766684 Review.

4

Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.

Suzuki E, Kapoor V, Cheung HK, Ling LE, DeLong PA, Kaiser LR, Albelda SM. Suzuki E, et al. Clin Cancer Res. 2004 Sep 1;10(17):5907-18. doi: 10.1158/1078-0432.CCR-03-0611. Clin Cancer Res. 2004. PMID: 15355924

5

Analysis of the immunologic response generated by Ad.IFN-beta during successful intraperitoneal tumor gene therapy.

Odaka M, Wiewrodt R, DeLong P, Tanaka T, Zhang Y, Kaiser L, Albelda S. Odaka M, et al. Mol Ther. 2002 Aug;6(2):210-8. doi: 10.1006/mthe.2002.0656. Mol Ther. 2002. PMID: 12161187 Free article.

6

Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.

Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S, Chang M, Lanuti M, Black ME, Kaiser LR, Albelda SM. Wiewrodt R, et al. Cancer Gene Ther. 2003 May;10(5):353-64. doi: 10.1038/sj.cgt.7700589. Cancer Gene Ther. 2003. PMID: 12719705

7

Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transfer.

Kucharczuk JC, Elshami AA, Zhang HB, Smythe WR, Hwang HC, Tomlinson JS, Amin KM, Litzky LA, Albelda SM, Kaiser LR. Kucharczuk JC, et al. Ann Thorac Surg. 1995 Sep;60(3):593-7; discussion 597-8. doi: 10.1016/0003-4975(95)00507-H. Ann Thorac Surg. 1995. PMID: 7677485 Free article.

8

Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates.

Kucharczuk JC, Raper S, Elshami AA, Amin KM, Sterman DH, Wheeldon EB, Wilson JM, Litzky LA, Kaiser LR, Albelda SM. Kucharczuk JC, et al. Hum Gene Ther. 1996 Dec 1;7(18):2225-33. doi: 10.1089/hum.1996.7.18-2225. Hum Gene Ther. 1996. PMID: 8953313

9

An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potent antitumoral efficacy but no toxicity to normal cell.

Tsukuda K, Wiewrodt R, Molnar-Kimber K, Jovanovic VP, Amin KM. Tsukuda K, et al. Cancer Res. 2002 Jun 15;62(12):3438-47. Cancer Res. 2002. PMID: 12067986

10

The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase gene.

Elshami AA, Kucharczuk JC, Sterman DH, Smythe WR, Hwang HC, Amin KM, Litzky LA, Albelda SM, Kaiser LR. Elshami AA, et al. Ann Surg. 1995 Sep;222(3):298-307; 307-10. doi: 10.1097/00000658-199509000-00008. Ann Surg. 1995. PMID: 7677460 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year